123.54
price up icon24.78%   24.53
after-market Handel nachbörslich: 123.74 0.20 +0.16%
loading
Schlusskurs vom Vortag:
$99.01
Offen:
$106.91
24-Stunden-Volumen:
6.79M
Relative Volume:
3.95
Marktkapitalisierung:
$18.99B
Einnahmen:
$4.28B
Nettoeinkommen (Verlust:
$1.26B
KGV:
15.65
EPS:
7.8957
Netto-Cashflow:
$943.00M
1W Leistung:
+23.40%
1M Leistung:
+30.08%
6M Leistung:
+59.20%
1J Leistung:
-14.29%
1-Tages-Spanne:
Value
$106.12
$123.93
1-Wochen-Bereich:
Value
$94.00
$123.93
52-Wochen-Spanne:
Value
$68.70
$156.66

Illumina Inc Stock (ILMN) Company Profile

Name
Firmenname
Illumina Inc
Name
Telefon
(858) 202-4500
Name
Adresse
5200 ILLUMINA WAY, SAN DIEGO, CA
Name
Mitarbeiter
8,970
Name
Twitter
@illumina
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
ILMN's Discussions on Twitter

Vergleichen Sie ILMN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
ILMN
Illumina Inc
123.54 15.22B 4.28B 1.26B 943.00M 7.8957
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
567.39 210.04B 43.74B 6.59B 6.11B 17.30
Diagnostics & Research icon
DHR
Danaher Corp
215.38 151.90B 24.27B 3.50B 5.02B 4.8589
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
629.51 50.29B 4.04B 985.66M 774.34M 12.01
Diagnostics & Research icon
A
Agilent Technologies Inc
146.36 40.64B 6.79B 1.22B 1.09B 4.2644
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
216.46 36.86B 15.90B 1.28B 2.21B 7.2842

Illumina Inc Stock (ILMN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-08-12 Herabstufung Daiwa Securities Outperform → Neutral
2025-07-11 Herabstufung Scotiabank Sector Outperform → Sector Perform
2025-03-04 Bestätigt Citigroup Neutral
2025-02-28 Herabstufung HSBC Securities Buy → Hold
2025-02-10 Herabstufung Barclays Equal Weight → Underweight
2025-02-07 Herabstufung TD Cowen Buy → Hold
2024-12-11 Herabstufung Citigroup Buy → Neutral
2024-11-12 Fortgesetzt Morgan Stanley Equal-Weight
2024-10-17 Hochstufung HSBC Securities Hold → Buy
2024-08-28 Hochstufung Argus Hold → Buy
2024-08-16 Hochstufung Daiwa Securities Neutral → Buy
2024-08-14 Hochstufung Barclays Underweight → Equal Weight
2024-08-14 Hochstufung TD Cowen Hold → Buy
2024-07-10 Hochstufung Citigroup Neutral → Buy
2024-06-03 Fortgesetzt Jefferies Hold
2024-01-16 Herabstufung HSBC Securities Buy → Hold
2024-01-04 Herabstufung TD Cowen Outperform → Market Perform
2023-12-18 Hochstufung Scotiabank Sector Perform → Sector Outperform
2023-12-15 Hochstufung Bernstein Underperform → Mkt Perform
2023-12-14 Eingeleitet Guggenheim Buy
2023-12-14 Eingeleitet Stephens Overweight
2023-12-13 Eingeleitet Wolfe Research Outperform
2023-12-12 Herabstufung BofA Securities Neutral → Underperform
2023-12-11 Hochstufung Citigroup Sell → Neutral
2023-11-10 Herabstufung Canaccord Genuity Buy → Hold
2023-09-28 Eingeleitet Bernstein Underperform
2023-07-05 Fortgesetzt JP Morgan Neutral
2023-01-25 Herabstufung Argus Buy → Hold
2023-01-05 Eingeleitet Scotiabank Sector Perform
2022-12-12 Herabstufung Citigroup Neutral → Sell
2022-12-07 Eingeleitet RBC Capital Mkts Outperform
2022-10-04 Hochstufung SVB Leerink Mkt Perform → Outperform
2022-09-28 Hochstufung Evercore ISI In-line → Outperform
2022-08-25 Eingeleitet Credit Suisse Neutral
2022-07-13 Herabstufung Barclays Equal Weight → Underweight
2022-01-18 Hochstufung Stifel Hold → Buy
2022-01-11 Hochstufung Barclays Underweight → Equal Weight
2022-01-07 Hochstufung BofA Securities Underperform → Neutral
2022-01-06 Fortgesetzt Morgan Stanley Equal-Weight
2022-01-06 Fortgesetzt Piper Sandler Overweight
2021-10-15 Fortgesetzt Cowen Outperform
2021-08-19 Herabstufung SVB Leerink Outperform → Mkt Perform
2021-06-01 Hochstufung Evercore ISI Underperform → In-line
2021-03-31 Herabstufung Atlantic Equities Overweight → Neutral
2021-03-31 Hochstufung Canaccord Genuity Hold → Buy
2021-03-03 Eingeleitet Barclays Underweight
2020-12-22 Hochstufung Piper Sandler Neutral → Overweight
2020-12-17 Hochstufung BTIG Research Neutral → Buy
2020-10-13 Herabstufung Guggenheim Buy → Neutral
2020-09-30 Eingeleitet Atlantic Equities Overweight
2020-09-29 Herabstufung Wolfe Research Outperform → Peer Perform
2020-09-22 Herabstufung Stifel Buy → Hold
2020-09-22 Herabstufung UBS Buy → Neutral
2020-09-21 Hochstufung Guggenheim Neutral → Buy
2020-09-21 Herabstufung JP Morgan Overweight → Neutral
2020-09-09 Eingeleitet Morgan Stanley Equal-Weight
2020-08-07 Herabstufung Evercore ISI In-line → Underperform
2020-08-07 Herabstufung Piper Sandler Overweight → Neutral
2020-07-07 Herabstufung Guggenheim Buy → Neutral
2020-04-24 Herabstufung Citigroup Buy → Neutral
2020-04-21 Herabstufung Robert W. Baird Outperform → Neutral
2020-01-08 Eingeleitet Wells Fargo Underweight
2020-01-07 Eingeleitet Citigroup Buy
2020-01-02 Herabstufung Evercore ISI Outperform → In-line
2019-11-15 Eingeleitet Stifel Buy
2019-10-25 Eingeleitet Guggenheim Buy
Alle ansehen

Illumina Inc Aktie (ILMN) Neueste Nachrichten

pulisher
Nov 01, 2025

Illumina (NASDAQ:ILMN) Stock Price Expected to Rise, TD Cowen Analyst Says - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

JPMorgan Chase & Co. Increases Illumina (NASDAQ:ILMN) Price Target to $105.00 - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

Illumina (ILMN) Jumps 24.8% on Earnings Beat - Insider Monkey

Nov 01, 2025
pulisher
Nov 01, 2025

What moving averages say about Illumina Inc.July 2025 Pullbacks & Free Growth Oriented Trading Recommendations - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Should I buy Illumina Inc. (ILU) stock before earnings season2025 Support & Resistance & Free Safe Capital Growth Stock Tips - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Illumina (NASDAQ:ILMN) Shares Gap Up After Earnings Beat - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

Combining machine learning predictions for Illumina Inc.July 2025 Levels & Low Drawdown Momentum Ideas - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Illumina (NASDAQ:ILMN) Given New $142.00 Price Target at Evercore ISI - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

Illumina (NASDAQ:ILMN) Stock Price Expected to Rise, UBS Group Analyst Says - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

What momentum indicators show for Illumina Inc. stockFed Meeting & Real-Time Buy Signal Alerts - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Barclays Maintains Illumina (ILMN) Underweight Recommendation - Nasdaq

Nov 01, 2025
pulisher
Nov 01, 2025

Is Illumina Inc. stock safe for conservative investorsPortfolio Update Summary & AI Forecast for Swing Trade Picks - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

4,386 Shares in Illumina, Inc. $ILMN Acquired by Earned Wealth Advisors LLC - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

Why Illumina Inc. (ILU) stock benefits from AI revolutionJuly 2025 Decliners & Consistent Return Strategy Ideas - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Illumina (ILMN) Returns to Profitability, Undervalued Versus Peers but Growth Lags Market - Yahoo Finance

Nov 01, 2025
pulisher
Nov 01, 2025

Illumina, Inc. $ILMN Shares Acquired by Fjarde AP Fonden Fourth Swedish National Pension Fund - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

Keybank National Association OH Decreases Position in Illumina, Inc. $ILMN - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

Y Intercept Hong Kong Ltd Has $2.41 Million Stock Position in Illumina, Inc. $ILMN - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

Will Illumina Inc. (ILU) stock test record highs in 2025Quarterly Trade Review & Technical Pattern Based Buy Signals - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Why Illumina Inc. stock is considered a top pickGap Down & Verified Momentum Stock Watchlist - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Analyzing Illumina Inc. with risk reward ratio chartsJuly 2025 Drop Watch & Weekly Setup with High ROI Potential - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Can Illumina Inc. (ILU) stock surprise with quarterly resultsBreakout Watch & Free Growth Oriented Trading Recommendations - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Illumina, Inc. (ILMN) Stock Forecasts - Yahoo! Finance Canada

Oct 31, 2025
pulisher
Oct 31, 2025

Illumina (NASDAQ:ILMN) Issues Earnings Results - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Illumina’s Strategic Moves Propel Share Price - timothysykes.com

Oct 31, 2025
pulisher
Oct 31, 2025

Illumina (NASDAQ:ILMN) Releases FY 2025 Earnings Guidance - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Illumina Stock Soaring – What’s Next? - StocksToTrade

Oct 31, 2025
pulisher
Oct 31, 2025

Illumina, Inc. (ILMN) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada

Oct 31, 2025
pulisher
Oct 31, 2025

U.S. Indexes Closed Up Friday; Illumina Topped Leaders - Barron's

Oct 31, 2025
pulisher
Oct 31, 2025

Illumina Stock Springs Back: Investment Alert? - timothysykes.com

Oct 31, 2025
pulisher
Oct 31, 2025

Illumina Inc reports results for the quarter ended September 30Earnings Summary - TradingView

Oct 31, 2025
pulisher
Oct 31, 2025

China’s DNA Sequencing Market to Grow at 21.5% CAGR by 2030 - GlobeNewswire Inc.

Oct 31, 2025
pulisher
Oct 31, 2025

'Hopeful' We'll Find Long-term Solution On China: Illumina CEO - MarketScreener

Oct 31, 2025
pulisher
Oct 31, 2025

Evercore ISI Group Maintains Illumina (ILMN) Outperform Recommendation - Nasdaq

Oct 31, 2025
pulisher
Oct 31, 2025

Research Alert: CFRA Raises Rating On Shares Of Illumina, Inc. To Buy From Hold - 富途牛牛

Oct 31, 2025
pulisher
Oct 31, 2025

Illumina Raises Guidance As Strong Quarter Lifts Shares - Finimize

Oct 31, 2025
pulisher
Oct 31, 2025

Why Illumina (ILMN) Stock Is Up Today - Yahoo Finance

Oct 31, 2025
pulisher
Oct 31, 2025

Illumina's Management Team Is Focused on Margin Expansion - Morningstar

Oct 31, 2025
pulisher
Oct 31, 2025

ILMN Q3 Deep Dive: Clinical Sequencing Momentum and Cost Discipline Drive Outperformance - Yahoo Finance

Oct 31, 2025
pulisher
Oct 31, 2025

UBS Adjusts Illumina Price Target to $120 From $110, Maintains Neutral Rating - MarketScreener

Oct 31, 2025
pulisher
Oct 31, 2025

Real time pattern detection on Illumina Inc. stockBond Market & Short-Term Trading Opportunity Alerts - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Momentum divergence signals in Illumina Inc. chart2025 Pullback Review & Expert Approved Momentum Ideas - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Technical analysis overview for Illumina Inc. stockStop Loss & Verified Momentum Stock Watchlist - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Canaccord Genuity raises Illumina stock price target to $112 on clinical growth - Investing.com

Oct 31, 2025
pulisher
Oct 31, 2025

Developing predictive dashboards with Illumina Inc. dataRate Cut & Low Risk Growth Stock Ideas - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Illumina Inc : JP Morgan Raises Target Price to $105 From $100 - 富途牛牛

Oct 31, 2025
pulisher
Oct 31, 2025

Illumina Inc (ILMN) Q3 2025 Earnings Call Highlights: Strong EPS Growth and Strategic ... By GuruFocus - Investing.com Canada

Oct 31, 2025
pulisher
Oct 31, 2025

Is Illumina Inc. (ILU) stock a buy on weakness2025 Investor Takeaways & Weekly Momentum Picks - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Will Illumina Inc. stock remain a Wall Street favoriteTrend Reversal & Stepwise Swing Trade Plans - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Illumina Reports Steady Q3 2025 Earnings - TipRanks

Oct 31, 2025
pulisher
Oct 31, 2025

Will Illumina Inc. stock benefit from automation2025 Big Picture & Technical Confirmation Alerts - newser.com

Oct 31, 2025

Finanzdaten der Illumina Inc-Aktie (ILMN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
diagnostics_research DGX
$175.95
price up icon 0.11%
diagnostics_research WAT
$349.60
price up icon 1.95%
diagnostics_research LH
$253.96
price up icon 0.65%
$198.93
price up icon 2.96%
diagnostics_research MTD
$1,416.29
price up icon 2.85%
diagnostics_research IQV
$216.46
price down icon 0.00%
Kapitalisierung:     |  Volumen (24h):